市場調查報告書
商品編碼
1617123
到 2030 年傷口護理設備市場預測:按產品類型、操作模式、技術、應用、最終用戶和地區進行的全球分析Negative Pressure Wound Therapy Devices Market Forecasts to 2030 - Global Analysis by Product, Wound Type, Mode of Operation, Technology, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2024 年全球負壓傷口護理設備市場規模為 69.7 億美元,預計到 2030 年將達到 106.4 億美元,預測期內複合年成長率為 7.3%。
負壓傷口護理(NPWT) 設備是創新的醫療設備,利用調節負壓(抽吸)來幫助慢性和複雜傷口的癒合。這種治療可以減少水腫,增加血流量,並有助於清除傷口中多餘的液體,加速組織再生和健康組織的發展。 NPWT 設備通常包括引流管、敷料或傷口敷料以及產生負壓的幫浦。這種治療方法通常用於治療燒傷、手術傷口、褥瘡和糖尿病潰瘍。 NPWT 設備在現代創傷護理管理中至關重要,因為它們可以增強氧氣輸送和組織灌注,降低感染風險並加速癒合。
慢性傷口增加
糖尿病性潰瘍、靜脈潰瘍等慢性傷口的盛行率日益增加,正在推動傷口護理(NPWT) 設備市場的發展。慢性傷口的早期癒合和感染預防需要先進的治療方案。 NPWT 設備作為一種有效的治療方法越來越受歡迎,因為它們可以改善血流、促進組織再生並最大限度地減少疤痕。由於全球慢性病的流行,對 NPWT 設備的需求增加,市場正在擴大。
併發症的風險
與傷口護理(NPWT) 設備相關的併發症風險限制了市場成長,因為使用不當可能導致組織損傷、感染和創傷治療延遲。這些風險可能會限制資源匱乏地區的採用,因為它們需要熟練的醫療專業人員來正確安裝和監測。此外,由於潛在的副作用,患者可能會避免使用 NPWT,尤其是在居家醫療中。因此,適當的培訓和監督的需要是更廣泛的市場擴張的障礙。
技術進步
技術創新透過提高設備性能、便攜性和使用便利性對市場產生重大影響。更小、更有效、對患者友善的 NPWT 系統是提高患者依從性和擴大使用範圍的技術創新的一個例子。無線監控、即時回饋和可調節設定的進步使這些設備更加有效,並減少了恢復時間和併發症。由於這些發展,對 NPWT 設備的需求不斷增加,特別是在醫院和居家照護環境中。
使用複雜性
使用負壓傷口護理(NPWT) 設備的複雜性限制了其廣泛採用。這些設備通常需要醫療保健提供者的專門培訓,以確保正確的應用和監控。此外,某些模型很難讓患者獨立使用,尤其是在居家照護環境中。這種複雜性可能會導致治療錯誤、患者依從性降低以及營運成本增加。因此,對專業知識和使用者培訓的需求已成為市場成長的障礙。
COVID-19 大流行最初因治療延遲、手術減少和供應鏈挑戰而擾亂了傷口護理(NPWT) 設備市場。醫院將資源轉移到 COVID-19 護理上,限制了對創傷護理的關注。然而,隨著醫療保健系統的復甦,人們對有效傷口管理(尤其是慢性傷口和手術傷口)的認知不斷提高,正在重振對 NPWT 設備的需求,並加速疫情後的市場成長。
預計組織再生領域在預測期內將是最大的。
NPWT 刺激組織生長、改善血液循環並促進細胞再生,使其在治療複雜的慢性傷口方面非常有效。隨著人們越來越重視改善患者復原結果和減少併發症,對 NPWT 裝置的需求不斷成長。這種組織再生的治療效果促進了 NPWT 設備的廣泛使用,也是已開發市場和新興市場市場發展的驅動力。
預計慢性傷口在預測期內的複合年成長率最高
由於糖尿病、靜脈潰瘍和壓瘡等疾病增加了慢性傷口的發生率並需要先進的治療解決方案,預計慢性傷口領域在預測期內將出現最高的複合年成長率。 NPWT 設備已成為處理這些傷口的首選,因為它們有助於加速癒合、減少感染並改善患者的治療效果。隨著全球慢性傷口負擔的增加,對 NPWT 設備的需求預計將成長,從而推動市場擴張。
由於糖尿病、手術部位感染和持續性傷口的增加,預計北美在預測期內將佔據最大的市場佔有率。由於人口老化和改進創傷護理產品的使用增加,市場正在擴大。完善的醫療基礎設施、不斷上升的醫療成本以及對使用微創療法改善患者治療效果的關注,進一步推動了北美(尤其是美國和加拿大)對 NPWT 設備的需求。
由於人口老化、慢性傷口、糖尿病和手術損傷的日益加劇,預計亞太地區在預測期內的複合年成長率最高。這些設備因其在加速創傷治療和降低感染風險方面的功效而越來越受歡迎。此外,中國、印度和日本等國家醫療保健基礎設施的改善和醫療技術的進步正在推動需求並促進該地區市場的快速成長。
According to Stratistics MRC, the Global Negative Pressure Wound Therapy Devices Market is accounted for $6.97 billion in 2024 and is expected to reach $10.64 billion by 2030 growing at a CAGR of 7.3% during the forecast period. Negative Pressure Wound Therapy (NPWT) Devices are innovative medical devices that use regulated negative pressure (suction) to aid healing in chronic or complex wounds. This treatment speeds up tissue regeneration and the development of healthy tissue by reducing edema, increasing blood flow, and assisting in the removal of extra fluid from the wound. NPWT devices usually include a drainage tube, a dressing or wound cover, and a pump that creates the negative pressure. The treatment is frequently used to treat burn injuries, surgical wounds, pressure sores, and diabetic ulcers. NPWT devices are essential to contemporary wound care management because they enhance oxygenation and tissue perfusion, which lowers the risk of infection and speeds up healing.
Rising Prevalence of Chronic Wounds
The increasing prevalence of chronic wounds, including as diabetic ulcers, pressure ulcers, and venous ulcers, is driving the Negative Pressure Wound Therapy (NPWT) Devices Market. Advanced treatment options are necessary for chronic wounds in order to promote faster healing and prevent infections. NPWT devices are becoming more and more popular as efficient remedies because they improve blood flow, encourage tissue regeneration, and minimize wound size. The market is growing as a result of the increased demand for NPWT devices brought on by the growth in the prevalence of chronic illnesses worldwide.
Risk of Complications
The risk of complications associated with Negative Pressure Wound Therapy (NPWT) devices limits market growth, as improper use can lead to tissue damage, infection, or delayed wound healing. These risks require skilled healthcare professionals for correct application and monitoring, which can restrict adoption in low-resource settings. The potential for adverse effects may also discourage patients from using NPWT, particularly in home care. As a result, the need for proper training and supervision hinders broader market expansion.
Technological Advancements
Technological innovations significantly impact the market by improving device performance, portability, and convenience of use. Smaller, more effective and patient-friendly NPWT systems are examples of innovations that increase patient compliance and broaden use. These gadgets are now more effective, lowering recovery durations and complications because to advancements in wireless monitoring, real-time feedback, and adjustable settings. The need for NPWT devices is growing as a result of these developments, especially in hospitals and home care settings.
Complexity in Usage
The complexity in usage of Negative Pressure Wound Therapy (NPWT) devices limits their widespread adoption. These devices often require specialized training for healthcare providers to ensure proper application and monitoring. Additionally, some models are difficult for patients to use independently, particularly in home care settings. This complexity can lead to errors in treatment, reduced patient compliance, and higher operational costs. As a result, the need for expertise and user training acts as a barrier to market growth.
The COVID-19 pandemic initially disrupted the Negative Pressure Wound Therapy (NPWT) Devices Market through delayed treatments, reduced surgeries, and supply chain challenges. Hospitals redirected resources towards COVID-19 care, limiting the focus on wound care. However, as healthcare systems recover, the demand for NPWT devices is rebounding, driven by increased awareness of effective wound management, especially for chronic and surgical wounds, thereby accelerating market growth post-pandemic.
The tissue regeneration segment is expected to be the largest during the forecast period
The tissue regeneration segment is expected to be the largest during the forecast period as NPWT stimulates tissue growth, improves blood circulation, and accelerates cellular regeneration, making it highly effective for treating complex and chronic wounds. As more focus is placed on improving patient recovery outcomes and reducing complications, the demand for NPWT devices grows. This therapeutic effect of tissue regeneration contributes to the widespread adoption of NPWT devices, fueling market growth in both developed and emerging healthcare markets.
The chronic wounds segment is expected to have the highest CAGR during the forecast period
The chronic wounds segment is expected to have the highest CAGR during the forecast period because conditions such as diabetes, venous ulcers, and pressure sores contribute to a higher incidence of chronic wounds, requiring advanced treatment solutions. NPWT devices help promote faster healing, reduce infection, and improve patient outcomes, making them a preferred choice for managing these wounds. As the global burden of chronic wounds increases, the demand for NPWT devices is expected to grow, boosting market expansion.
North America is anticipated to hold the largest market share during the forecast period due to increasing rates of diabetes, surgical site infections, and persistent wounds. The market is expanding due to the aging population and the growing use of improved wound care products. Further driving up demand for NPWT devices in North America, especially in the U.S. and Canada, are established healthcare infrastructures, increased healthcare spending, and a focus on enhancing patient outcomes using minimally invasive therapies.
Asia Pacific is anticipated to witness the highest CAGR over the forecast period owing to growing aging population, and rising incidences of chronic wounds, diabetes, and surgical injuries. These devices, which aid in faster wound healing and reduce infection risks, are gaining popularity due to their effectiveness. Additionally, improved healthcare infrastructure and advancements in medical technology in countries like China, India, and Japan are boosting demand, contributing to rapid market growth in the region.
Key players in the market
Some of the key players in Negative Pressure Wound Therapy Devices Market include 3M, 4L Health Co. Ltd., Alleva Medical, Cardinal Health, Carilex Medical, ConvaTec Group Plc, Cork Medical, LLC, DeRoyal Industries Inc., Genadyne, Haromed, Lohmann & Rauscher GmbH & Co. KG, Medela AG, Molnlycke Healthcare AB, Paul Hartmann AG, Pensar Medical, LLC, Smith+Nephew, Talley Group Ltd and Triage Meditech Pvt. Ltd.
In October 2024, Convatec collaborated with AbbVie for VYALEV therapy for the treatment of advanced Parkinson's disease in the United States.
In October 2024, Smith+Nephew announced that it has signed a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology - the only ultrasound device currently on the market to deliver 3D preoperative planning.
In July 2024, Smith+Nephew announced an exclusive digital and advanced analytics collaboration with Healthcare Outcomes Performance Company to focus on enhancing solutions for ASC customers, physicians, and their patients through HOPCo's digital health and analytics platforms, myrecovery and Vitals.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.